Sam Isaly, Orbimed Now Hold 53.3% of Response Biomedical

Sam Isaly‘s Orbimed Advisors focuses on healthcare investments, and it has now disclosed a change to its holdings of Response Biomedical Corp. (ADR)(OTCBB:RPBIF), a rapid on-site diagnostic test provider. The fund now holds 53.3% of the micro-cap’s outstanding shares, down from the 54.6% stake it last reported in 2012.


Disclosure: none

Recommended Reading:

Paul Singer Reiterates 6.4% Stake in Emulex, Reveals New Agreement in Play

Eric Bannasch’s Cadian Capital Lowers Stake in LogMeIn

Glenn Greenberg’s Brave Warrior Capital Cuts Stake in Higher One Holdings